Single answer
Is Arcutis Biotherapeutics Inc (ARQT) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
$1 invested is now $1.30 or 29.56%
(In 16 weeks 2 days 22 hours and 55 minutes .)
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Arcutis Biotherapeutics Inc is $33.33, which is $6.32 (23.40%) above the current price today's price.
Low target: $29.00 | High target: $37.00
Latest analyst updates
Recent rating and price target changes for this stock.
Company snapshot
A quick overview of the business and its public profile.
Arcutis Biotherapeutics Inc a biopharmaceutical company focuses on developing and commercializing treatments for dermatological diseases Its lead product candidate is ARQ151 a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis The company is also developing ARQ154 a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis ARQ252 a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo and ARQ255 a topical formulation of ARQ252 designed to reach deeper into the skin in order to treat alopecia areata The company was formerly known as Arcutis Inc and changed its name to Arcutis Biotherapeutics Inc in October 2019 Arcutis Biotherapeutics Inc was incorporated in 2016 and is headquartered in Westlake Village California
Website: https://www.arcutis.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.31. Cash flow to debt ratio: -0.29. Net profit margin: -13.94%. Inflation risk score: high (0.75/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Arcutis Biotherapeutics Inc is $52M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Arcutis Biotherapeutics Inc 10 years ago, but if you had invested on 2020-01-31 when the price was $21.80, you would have made a profit of $5.21 per share or 23.90%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.